Hormonal Effects on Drug Metabolism Through the CYP System: Perspectives on Their Potential Significance in the Era of Pharmacogenomics

Publisher： Bentham Science Publishers

E-ISSN： 1875-5917|5|4|439-448

ISSN： 1568-0088

Source： Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol.5, Iss.4, 2005-12, pp. : 439-448

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The potential of pharmacogenomics to treat drug addiction

By Haile Colin N   Kosten Thomas R  

Pharmacogenomics, Vol. 10, Iss. 12, 2009-12 ,pp. : 1883-1886

Future Medicine

Access to resources Recommend Favorite

Pregnancy and pharmacogenomics in the context of drug metabolism and response

By Helldén Anders   Madadi Parvaz  

Pharmacogenomics, Vol. 14, Iss. 14, 2013-11 ,pp. : 1779-1791

Future Medicine

Access to resources Recommend Favorite

Inhibition of hERG potassium channel by the antiarrhythmic agent mexiletine and its metabolite m‐hydroxymexiletine

By  

Pharmacology Research & Perspectives, Vol. 3, Iss. 5, 2015-10 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Payer perspectives on pharmacogenomics testing and drug development

By Epstein Robert S   Frueh Felix W   Geren Dawn   Hummer Doris   McKibbin Scott   O’’Connor Susan   Randhawa Gurvaneet   Zelman Benjamin  

Pharmacogenomics, Vol. 10, Iss. 1, 2009-01 ,pp. : 149-151

Future Medicine

Access to resources Recommend Favorite

Pharmacogenomics of adverse drug reactions: practical applications and perspectives

By Becquemont Laurent  

Pharmacogenomics, Vol. 10, Iss. 6, 2009-06 ,pp. : 961-969

Future Medicine

Access to resources Recommend Favorite